Literature DB >> 19060136

The pentapeptide repeat proteins MfpAMt and QnrB4 exhibit opposite effects on DNA gyrase catalytic reactions and on the ternary gyrase-DNA-quinolone complex.

Audrey Mérens1, Stéphanie Matrat, Alexandra Aubry, Christine Lascols, Vincent Jarlier, Claude-James Soussy, Jean-Didier Cavallo, Emmanuelle Cambau.   

Abstract

MfpA(Mt) and QnrB4 are two newly characterized pentapeptide repeat proteins (PRPs) that interact with DNA gyrase. The mfpA(Mt) gene is chromosome borne in Mycobacterium tuberculosis, while qnrB4 is plasmid borne in enterobacteria. We expressed and purified the two PRPs and compared their effects on DNA gyrase, taking into account host specificity, i.e., the effect of MfpA(Mt) on M. tuberculosis gyrase and the effect of QnrB4 on Escherichia coli gyrase. Whereas QnrB4 inhibited E. coli gyrase activity only at concentrations higher than 30 microM, MfpA(Mt) inhibited all catalytic reactions of the M. tuberculosis gyrase described for this enzyme (supercoiling, cleavage, relaxation, and decatenation) with a 50% inhibitory concentration of 2 microM. We showed that the D87 residue in GyrA has a major role in the MfpA(Mt)-gyrase interaction, as D87H and D87G substitutions abolished MfpA(Mt) inhibition of M. tuberculosis gyrase catalytic reactions, while A83S modification did not. Since MfpA(Mt) and QnrB4 have been involved in resistance to fluoroquinolones, we measured the inhibition of the quinolone effect in the presence of each PRP. QnrB4 reversed quinolone inhibition of E. coli gyrase at 0.1 microM as described for other Qnr proteins, but MfpA(Mt) did not modify M. tuberculosis gyrase inhibition by fluoroquinolones. Crossover experiments showed that MfpA(Mt) also inhibited E. coli gyrase function, while QnrB4 did not reverse quinolone inhibition of M. tuberculosis gyrase. In conclusion, our in vitro experiments showed that MfpA(Mt) and QnrB4 exhibit opposite effects on DNA gyrase and that these effects are protein and species specific.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19060136      PMCID: PMC2648189          DOI: 10.1128/JB.01205-08

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  47 in total

1.  Use of in vitro topoisomerase II assays for studying quinolone antibacterial agents.

Authors:  J F Barrett; T D Gootz; P R McGuirk; C A Farrell; S A Sokolowski
Journal:  Antimicrob Agents Chemother       Date:  1989-10       Impact factor: 5.191

Review 2.  Structure, molecular mechanisms, and evolutionary relationships in DNA topoisomerases.

Authors:  Kevin D Corbett; James M Berger
Journal:  Annu Rev Biophys Biomol Struct       Date:  2004

3.  Structure and distribution of pentapeptide repeats in bacteria.

Authors:  A Bateman; A G Murzin; S A Teichmann
Journal:  Protein Sci       Date:  1998-06       Impact factor: 6.725

4.  Crystal structure of the breakage-reunion domain of DNA gyrase.

Authors:  J H Morais Cabral; A P Jackson; C V Smith; N Shikotra; A Maxwell; R C Liddington
Journal:  Nature       Date:  1997-08-28       Impact factor: 49.962

Review 5.  Mycobacterial cell wall: structure and role in natural resistance to antibiotics.

Authors:  V Jarlier; H Nikaido
Journal:  FEMS Microbiol Lett       Date:  1994-10-15       Impact factor: 2.742

6.  Quinolone resistance from a transferable plasmid.

Authors:  L Martínez-Martínez; A Pascual; G A Jacoby
Journal:  Lancet       Date:  1998-03-14       Impact factor: 79.321

Review 7.  Fluoroquinolones, tuberculosis, and resistance.

Authors:  Amy Sarah Ginsburg; Jacques H Grosset; William R Bishai
Journal:  Lancet Infect Dis       Date:  2003-07       Impact factor: 25.071

8.  Analysis of the NH2-terminal 87th amino acid of Escherichia coli GyrA in quinolone-resistance.

Authors:  M Yonezawa; M Takahata; N Banzawa; N Matsubara; Y Watanabe; H Narita
Journal:  Microbiol Immunol       Date:  1995       Impact factor: 1.955

9.  Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China.

Authors:  Minggui Wang; John H Tran; George A Jacoby; Yingyuan Zhang; Fu Wang; David C Hooper
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

10.  Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence.

Authors:  S T Cole; R Brosch; J Parkhill; T Garnier; C Churcher; D Harris; S V Gordon; K Eiglmeier; S Gas; C E Barry; F Tekaia; K Badcock; D Basham; D Brown; T Chillingworth; R Connor; R Davies; K Devlin; T Feltwell; S Gentles; N Hamlin; S Holroyd; T Hornsby; K Jagels; A Krogh; J McLean; S Moule; L Murphy; K Oliver; J Osborne; M A Quail; M A Rajandream; J Rogers; S Rutter; K Seeger; J Skelton; R Squares; S Squares; J E Sulston; K Taylor; S Whitehead; B G Barrell
Journal:  Nature       Date:  1998-06-11       Impact factor: 49.962

View more
  22 in total

1.  Structural and biochemical analysis of the pentapeptide repeat protein EfsQnr, a potent DNA gyrase inhibitor.

Authors:  Subray S Hegde; Matthew W Vetting; Lesley A Mitchenall; Anthony Maxwell; John S Blanchard
Journal:  Antimicrob Agents Chemother       Date:  2010-10-11       Impact factor: 5.191

Review 2.  Plasmid-mediated quinolone resistance.

Authors:  George A Jacoby; Jacob Strahilevitz; David C Hooper
Journal:  Microbiol Spectr       Date:  2014-10

3.  Phylogenetic analysis of chromosomally determined qnr and related proteins.

Authors:  George A Jacoby; David C Hooper
Journal:  Antimicrob Agents Chemother       Date:  2013-01-14       Impact factor: 5.191

4.  Interactions between QnrB, QnrB mutants, and DNA gyrase.

Authors:  Eu Suk Kim; Chunhui Chen; Molly Braun; Hyo Youl Kim; Ryo Okumura; Yin Wang; George A Jacoby; David C Hooper
Journal:  Antimicrob Agents Chemother       Date:  2015-06-22       Impact factor: 5.191

5.  Structure of QnrB1, a plasmid-mediated fluoroquinolone resistance factor.

Authors:  Matthew W Vetting; Subray S Hegde; Minghua Wang; George A Jacoby; David C Hooper; John S Blanchard
Journal:  J Biol Chem       Date:  2011-05-19       Impact factor: 5.157

Review 6.  Mechanisms of drug resistance: quinolone resistance.

Authors:  David C Hooper; George A Jacoby
Journal:  Ann N Y Acad Sci       Date:  2015-07-17       Impact factor: 5.691

7.  Comparative analysis of an IncR plasmid carrying armA, blaDHA-1 and qnrB4 from Klebsiella pneumoniae ST37 isolates.

Authors:  Qinglan Guo; Caressa Nicole Spychala; Christi Lee McElheny; Yohei Doi
Journal:  J Antimicrob Chemother       Date:  2016-01-07       Impact factor: 5.790

Review 8.  Plasmid-mediated quinolone resistance: a multifaceted threat.

Authors:  Jacob Strahilevitz; George A Jacoby; David C Hooper; Ari Robicsek
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

9.  QnrS1 structure-activity relationships.

Authors:  María M Tavío; George A Jacoby; David C Hooper
Journal:  J Antimicrob Chemother       Date:  2014-04-11       Impact factor: 5.790

10.  Protective effect of Qnr on agents other than quinolones that target DNA gyrase.

Authors:  George A Jacoby; Marian A Corcoran; David C Hooper
Journal:  Antimicrob Agents Chemother       Date:  2015-08-03       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.